The U.S. Pharmacy Administration approves Modner and Pfizer's new crown vaccine for emergency use in 6 months and above

According to the latest revision of the U.S. Pharmaceutical Management Bureau, the Modner vaccine is used in two to 17 years old for two doses, which is separated by 1 month; Pfizer vaccine is used in 6 months to 4 years.The interval is 3 weeks, and the third agent and the second dose are at least 8 weeks.

The U.S. Pharmaceutical Administration has previously approved the Modner vaccine in the age of 18 and above, and Pfizer vaccine is used at the age of 5 and above.

The US Pharmaceutical Administration said in a statement that the approval of this authorization is based on the strict and comprehensive evaluation and analysis of the safety, effectiveness and production data of the two vaccines.The U.S. Pharmaceutical Administration believes that the two vaccines are used in the known and potential benefits of the children's group than their known and potential risks.Before making a decision, the US Pharmaceutical Administration consulted the opinions of its independent expert committee.

In the statement, the director of the US Pharmaceutical Administration, Robert Calif to say that it is hoped to approve the use of new crown vaccines for young children to protect the serious consequences of new crowns, including hospitalization and death.

- END -